Roche Holding AG RHHBY:OTCQX

RT Quote | Exchange | USD
Last | 03/05/21 EST
40.59quote price arrow up+0.09 (+0.22%)
Volume
2,185,854
52 week range
35.04 - 47.15

...

Loading . . .

KEY STATS

  • Open40.32
  • Day High40.63
  • Day Low39.80
  • Prev Close40.50
  • 52 Week High47.15
  • 52 Week High Date09/18/20
  • 52 Week Low35.04
  • 52 Week Low Date03/23/20
  • Market Cap280.091B
  • Shares Out6.901B
  • 10 Day Average Volume0.00M
  • Dividend1.28
  • Dividend Yield3.15%
  • Beta0.52
  • 1 Year % Change-3.43

RATIOS/PROFITABILITY

  • EPS (TTM)2.02
  • P/E (TTM)20.11
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)25.127B
  • ROE (MRQ)44.72%
  • Revenue (MRQ)62.913B
  • Gross Margin (MRQ)71.73%
  • Net Margin (MRQ)22.95%
  • Debt To Equity (MRQ)43.86%

EVENTS

  • Earnings Date-
  • Ex Div Date03/18/2021
  • Div Amount1.2782
  • Split Date-
  • Split Factor-

QUOTE FINDER

Related Video

VIDEO4:0804:08
Weill Neurohub joins Genentech and Roche in accelerating neuroscience research

Profile

MORE
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...
Christoph Franz
Non-Executive Chairman
Alan Hippe
Chief Financial Officer
Claudia Boeckstiegel
General Counsel
Address
Grenzacherstr. 124
Basel
4058
Switzerland